D. E. Shaw & Co., Inc. Azenta, Inc. Transaction History

D. E. Shaw & Co., Inc.

$122 Billion
Q4 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Azenta, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 300,784 shares of AZTA stock, worth $13.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

300,784

Previous 465,798 35.43%

Holding current value

$13.7 Million

Previous $22.6 Million 33.35%

% of portfolio

0.01%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$40.37 - $51.57 $6.66 Million - $8.51 Million	-165,014 Reduced 35.43%	300,784 $15 Million
Q3 2024 Nov 14, 2024	BUY	$45.84 - $62.29 $2.7 Million - $3.66 Million	58,820 Added 14.45%	465,798 $22.6 Million
Q2 2024 Aug 14, 2024	SELL	$50.27 - $59.04 $10.8 Million - $12.7 Million	-214,888 Reduced 34.56%	406,978 $21.4 Million
Q1 2024 May 15, 2024	SELL	$57.82 - $67.51 $6.21 Million - $7.25 Million	-107,319 Reduced 14.72%	621,866 $37.5 Million
Q4 2023 Feb 14, 2024	SELL	$44.02 - $66.3 $9.5 Million - $14.3 Million	-215,801 Reduced 22.84%	729,185 $47.5 Million
Q3 2023 Nov 14, 2023	BUY	$44.08 - $57.76 $12.7 Million - $16.6 Million	287,685 Added 43.77%	944,986 $47.4 Million
Q2 2023 Aug 14, 2023	BUY	$36.45 - $46.68 $9.87 Million - $12.6 Million	270,877 Added 70.1%	657,301 $30.7 Million
Q1 2023 May 15, 2023	SELL	$39.51 - $61.95 $4.26 Million - $6.69 Million	-107,947 Reduced 21.84%	386,424 $17.2 Million
Q4 2022 Feb 14, 2023	BUY	$38.6 - $62.07 $10.6 Million - $17 Million	273,552 Added 123.88%	494,371 $28.8 Million
Q3 2022 Nov 14, 2022	BUY	$42.86 - $77.02 $9.17 Million - $16.5 Million	214,051 Added 3162.69%	220,819 $9.46 Million
Q2 2022 Aug 15, 2022	BUY	$64.69 - $85.07 $437,821 - $575,753	6,768 New	6,768 $488,000
Q1 2022 May 16, 2022	SELL	$76.3 - $103.81 $2.62 Million - $3.56 Million	-34,279 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$92.98 - $124.15 $7.15 Million - $9.54 Million	-76,859 Reduced 69.16%	34,279 $3.54 Million
Q3 2021 Nov 15, 2021	SELL	$77.49 - $109.17 $7.66 Million - $10.8 Million	-98,861 Reduced 47.08%	111,138 $11.4 Million
Q2 2021 Aug 16, 2021	BUY	$86.59 - $107.47 $15.3 Million - $19 Million	176,931 Added 535.05%	209,999 $20 Million
Q1 2021 May 17, 2021	BUY	$66.32 - $90.93 $2.19 Million - $3.01 Million	33,068 New	33,068 $2.7 Million
Q3 2020 Nov 16, 2020	SELL	$42.77 - $56.69 $601,645 - $797,458	-14,067 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$26.54 - $44.24 $5.56 Million - $9.26 Million	-209,382 Reduced 93.7%	14,067 $622,000
Q1 2020 May 15, 2020	BUY	$22.69 - $44.14 $2.53 Million - $4.92 Million	111,494 Added 99.59%	223,449 $6.82 Million
Q4 2019 Feb 14, 2020	BUY	$35.49 - $48.05 $3.97 Million - $5.38 Million	111,955 New	111,955 $4.7 Million
Q2 2019 Aug 14, 2019	SELL	$29.53 - $41.1 $3.92 Million - $5.46 Million	-132,909 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$24.38 - $33.75 $323,912 - $448,402	13,286 Added 11.11%	132,909 $3.9 Million
Q4 2018 Feb 14, 2019	BUY	$23.22 - $35.29 $130,612 - $198,506	5,625 Added 4.93%	119,623 $3.13 Million
Q3 2018 Nov 14, 2018	BUY	$28.71 - $39.6 $827,393 - $1.14 Million	28,819 Added 33.83%	113,998 $3.99 Million
Q2 2018 Aug 14, 2018	BUY	$24.88 - $36.36 $800,912 - $1.17 Million	32,191 Added 60.75%	85,179 $2.78 Million
Q1 2018 May 15, 2018	SELL	$23.3 - $30.15 $2.39 Million - $3.09 Million	-102,599 Reduced 65.94%	52,988 $1.44 Million
Q4 2017 Feb 14, 2018	SELL	$22.54 - $34.39 $3.69 Million - $5.63 Million	-163,588 Reduced 51.25%	155,587 $3.71 Million
Q3 2017 Nov 14, 2017	BUY	$22.6 - $30.36 $7.21 Million - $9.69 Million	319,175	319,175 $9.69 Million

Others Institutions Holding AZTA

# of Institutions

337

Shares Held

51.8M

Call Options Held

192K

Put Options Held

320K

View Full List

About Azenta, Inc.

Ticker AZTA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 75,020,400
Market Cap $3.41B
Description
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sampl...

More about AZTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account